All Benjamin Rome articles
-
NewsDramatic reduction in prescribing of hepatitis C antivirals may leave many curable patients untreated
A new study analyzed a large national prescription database to estimate hepatitis C treatment courses over time and trends by patient and prescriber characteristics from 2013–2025. Prescriptions rose rapidly after direct-acting antivirals first became available, peaking in 2015, but then declined sharply through 2025.